Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

NCT01853605 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01853605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01853605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Lead sponsor
Allergan
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2003
Completion date
August 31, 2014
Enrollment
3,811 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast augmentation, breast implant revision, breast reconstruction